Doctors Want Their AI Dividend

Doximity’s 2026 Physician Compensation Report told a familiar story with an unexpected plot twist. Modest raises are still getting outpaced by not-so-modest inflation, but physicians now want a slice of all the AI-driven productivity gains.

Average physician pay rose 2% in 2025. The headline stat from nearly 23k surveys marked a significant slowdown from +3.7% the year before. It also trailed full-year inflation of 2.7%.

  • Neurosurgery once again led all specialties at $829k, interventional radiology grew fastest at 10.8%, and radiology was the only specialty to crack the top 10 for growth two years running.
  • The surgical specialist premium over primary care widened to 90.1% (from 87.3%), reversing three years of narrowing, while the gender pay gap sat unchanged at 26%.

The bigger story was AI’s growing impact. When Doximity asked who should primarily benefit financially if AI lets physicians complete more clinical work in the same amount of time, physicians primarily nominated themselves.

  • 44% said physicians (rising to 50% among PCPs), 20% said the gains should be shared, 17% picked patients, 11% picked their employers, and a whopping 2% picked payors.
  • There’s less agreement on the mechanics. 36% said physician compensation for a service should change if AI substantially reduces their time or effort for that service, while 43% said it should stay put.

Burnout is the bargaining power. The report lays out some compelling reasons why physicians feel they deserve some AI upside, and why they might actually be able to get it.

  • 82% of docs report being overworked, 66% are considering a career change, and the share considering early retirement jumped from 34% to 46% in a single year.
  • Those are some scary numbers all around, and despite all of the new tech promising to make life easier, 76% of physicians would trade lower pay for more autonomy or work-life balance.
  • Health systems and physician employers could try to bank all the AI efficiency gains for themselves, but they’re negotiating with a workforce that’s already eyeing the exits.

The Takeaway

Most payment models in healthcare ultimately put a price on physician time, so there’s inevitably going to be some serious discussions when AI starts impacting that time. Doximity’s report just showed that physicians are already pulling up chairs to the negotiating table.

Doximity Ramps Up AI With Pathway Acquisition

Doximity is setting out to prove that it’s more than “LinkedIn for doctors” after snapping up clinical reference AI startup Pathway for $63M. 

Clinical workflows are the new social media… or at least that’s the plot of Doximity’s growth story.

  • Act 1: Doximity’s newsfeed and networking features set the stage for pharma advertising by attracting physicians to the platform.
  • Act 2: Complementary workflow tools like scheduling, telehealth, and Doximity Dialer gave physicians a reason to stick around longer than their news sweep.
  • Act 3: The AI suite took engagement a step further with Doximity GPT and Doximity Scribe, which helped drive quarterly active users to a record 1M physicians in Q1.

Enter Pathway. The Montreal-based startup’s AI helps physicians answer questions at the bedside using information from Pathway Corpus, “one of the largest structured datasets in medicine” that spans nearly every guideline, journal, and landmark trial.

  • Pathway’s cross-linked structure reportedly allows it to understand complex drug interactions and score the strength of medical evidence, such as weighing validated clinical trials more than case studies.
  • The acquisition will bring that same “robustness” to the back-end of Doximity GPT, and the integration is already live for thousands of physician beta testers.

If you can’t beat ‘em, buy ‘em. It’s tough for physicians to see your pharma ads if they’re not using your platform, so Doximity is acquiring its own workflow solutions to keep users from venturing off to use competing products from OpenEvidence or Wolters Kluwer. 

  • Clinicians have also apparently been using Doximity GPT outside of office hours more than Doximity’s other tools, which helps with serving ads around the clock.
  • Doximity’s AI suite and workflow modules already account for over 20% of its ad revenue, and it now expects that share to overtake its newsfeed in the next few years.

The Takeaway

Doximity is looking to make AI the star of its next act, and if OpenEvidence doesn’t want to share its script, then Pathway will have to steal the show.

Doximity Adds Physician Scheduling With Amion Acquisition

Healthcare networking platform Doximity is expanding beyond its role as “the LinkedIn for doctors” with the announcement that it is acquiring on-call physician scheduling app Amion for $53.5M.

  • Amion adds a key component to Doximity’s physician cloud services by integrating scheduling into its existing suite of messaging, referral, and telehealth tools.
  • Doximity has over a million doctors as verified members, ranking it among the largest networks of healthcare professionals in the US.
  • The company went public last year at a valuation of $7B and has since found success with its strategy of cultivating a community of medical workers that it can then offer tools to in order to improve their day-to-day workflows.
  • In its recent conference call with investors, Doximity revealed that its revenue climbed 67% year-over-year to $97.9M, netting a healthy pre-tax earnings of $47M.

The Takeaway

Doximity CEO Jeff Tangney stated that the Amion move was primarily a product acquisition for the company, adding a valuable subscription business that manages over 200k physician schedules across thousands of hospitals.

By expanding Doximity’s roster of collaboration products, Amion’s scheduling tools have the potential to improve engagement across its acquirer’s entire network.

Get the top digital health stories right in your inbox